September 19, 2016
1 min read
Save

AACR receives PHL Life Sciences Ultimate Solution Award

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

PHL Life Sciences, a division of the Philadelphia Convention and Visitors Bureau, presented the PHL Life Sciences Ultimate Solution Award to the American Association for Cancer Research and its CEO, Margaret Foti, PhD, MD (hc).

The award recognizes an individual or organization that has raised Philadelphia’s profile as a life sciences meeting and convention destination.

#

The American Association for Cancer Research and its CEO, Margaret Foti, PhD, MD (hc), received the PHL Life Sciences Ultimate Solution Award. Foti (second from left) is pictured with Julie Coker Graham, president and CEO of the Philadelphia Convention and Visitors Bureau; Bonnie Grant, executive director of PHL Life Sciences; and David King, co-chair of PHL Life Sciences.

AACR, headquartered in Philadelphia, is dedicated to advancing cancer research and its mission to prevent and cure cancer.

More than 19,300 people attended the association’s 2015 annual meeting in Philadelphia. An estimated 1,500 of the association’s 37,000 members worldwide live and work in the Philadelphia region.

“We at the American Association for Cancer Research are very proud to have helped catalyze the progress made against cancer through our many programs, services, and initiatives. I am deeply honored to accept this award from PHL Life Sciences,” Foti said in a press release. “The AACR is at the center of the cancer research world. Philadelphia is home to world-class hospitals, research centers, universities, and cancer institutes, including four NCI-designated cancer centers, and we are fortunate to be able to collaborate extensively with our local renowned scientific network.

“We could not achieve our mission to prevent and cure cancer without such a powerful, connected scientific community, and it is through our strong collaboration that we are able to reach out and touch the lives of cancer patients from Philadelphia and throughout the world,” Foti added. “As the CEO of the AACR, I feel privileged to be a part of this collaborative spirit and to witness the progress that has been achieved.”